| mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.0019 |
0.9 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
1 |
| mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.0028 |
1 |
| mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
0.0029 |
1 |
| mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
-0.0027 |
1 |
| mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
0.0019 |
1 |
| mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
0.0021 |
1 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0019 |
1 |
| mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
0.0024 |
1 |